Indivior Pharmaceuticals Inc ( INDV) - Key Metrics
INDV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.86 | $0.82 | -$1.77 | -$1.96 |
| 2025Q3 | $2.51 | $0.34 | -$0.31 | -$0.47 |
| 2025Q2 | $2.44 | $0.15 | $1.34 | $1.20 |
| 2025Q1 | $2.15 | $0.38 | $0.61 | $0.57 |
INDV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 10.89 |
| 2025Q3 | ? | 17.94 |
| 2025Q2 | ? | 25.32 |
| 2025Q1 | ? | 6.27 |
INDV
Price: $40.45
52 week price:
Earnings Per Share: 1.95 USD
P/E Ratio: 20.83
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 5.0 billion